T-0126

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameT-0126
Drug Alias Namemicrosomal triglyceride transfer protein inhibitor (Tanabe)T-0126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A